21.10.25 – 22.10.25 • Liverpool, UK
ELRIG’s Drug Discovery 2025
We will exhibit and present Myllia's primary cell CRISPR screening platform at Drug Discovery 2025 in Liverpool, UK
Join Myllia’s VP R&D Lukas Badertscher, Project Lead Stefanie Fellinger and BD Manager Henrik Schmidt at Drug Discovery 2025! Are you interested in functional genomics, target discovery and immunology? If so, please get in touch with Myllia directly as we are pioneers in large-scale CRISPR screening in primary human immune cells.
We’ve developed VISTA – the new CRISPR screening platform enabling target discovery in primary human macrophages and dendritic cells!
Event website:
ELRIG’s Drug Discovery 2025
Attendee(s):
Stefanie Fellinger (LinkedIn)
Lukas Badertscher (LinkedIn)
Henrik Schmidt (LinkedIn)